Member of the Association of American Physicians
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Diabetes mellitus, Cell biology and Metabolomics. His research investigates the connection between Internal medicine and topics such as Cardiology that intersect with problems in Peripheral. The Diabetes mellitus study combines topics in areas such as Framingham Heart Study, Metabolome and Amino acid.
He has included themes like Glycolysis, Biochemistry and Cellular differentiation in his Cell biology study. His Metabolomics study combines topics in areas such as Model organism, Disease biomarker, Biological pathway, Pathology and Metabolic pathway. The various areas that he examines in his Diabetes risk study include Phenylalanine, Valine, Insulin, Aromatic amino acids and Leucine.
Robert E. Gerszten focuses on Internal medicine, Endocrinology, Metabolomics, Cardiology and Computational biology. His Internal medicine research integrates issues from Diabetes mellitus and Oncology. Robert E. Gerszten interconnects Prospective cohort study and Case-control study in the investigation of issues within Diabetes mellitus.
Insulin resistance, Insulin, Body mass index, Metabolism and Glucose homeostasis are the subjects of his Endocrinology studies. His studies in Metabolomics integrate themes in fields like Biochemistry, Disease and Physiology. His work carried out in the field of Computational biology brings together such families of science as Proteomics, Proteomic Profiling and Genomics.
Robert E. Gerszten mostly deals with Internal medicine, Disease, Metabolomics, Proteomics and Endocrinology. His study looks at the relationship between Internal medicine and fields such as Cardiology, as well as how they intersect with chemical problems. The study incorporates disciplines such as Myeloid, Proteome, Genetics and Locus in addition to Disease.
His Metabolomics research is multidisciplinary, relying on both Environmental health, Physiology, Dietary intake and Risk factor. His Proteomics research is multidisciplinary, incorporating elements of Multiplex and Computational biology. His work on Creatinine, Kidney and Homocysteine as part of general Endocrinology study is frequently linked to Renal phosphate excretion, bridging the gap between disciplines.
Robert E. Gerszten mainly investigates Disease, Internal medicine, Locus, Genetics and Endocrinology. His Disease research incorporates elements of Physical medicine and rehabilitation and Resistance training. Nephrology, Kidney, Odds ratio, Interquartile range and Retrospective cohort study are among the areas of Internal medicine where the researcher is concentrating his efforts.
His studies deal with areas such as CXCL16, Mediator, ABO blood group system and Proteomic Profiling as well as Locus. His Genetics study combines topics from a wide range of disciplines, such as Adipose tissue and Insulin resistance. His work on Homeostasis as part of general Endocrinology research is often related to Renal phosphate excretion, thus linking different fields of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Heather R. Christofk;Matthew G. Vander Heiden;Marian H. Harris;Arvind Ramanathan.
Metabolite profiles and the risk of developing diabetes
Thomas J Wang;Martin G Larson;Martin G Larson;Ramachandran S Vasan;Ramachandran S Vasan;Susan Cheng;Susan Cheng;Susan Cheng.
Nature Medicine (2011)
MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions.
Robert E. Gerszten;Eduardo A. Garcia-Zepeda;Yaw-Chyn Lim;Yaw-Chyn Lim;Masayuki Yoshida.
MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis
S. Hani Najafi-Shoushtari;Fjoralba Kristo;Yingxia Li;Toshi Shioda.
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
Francesco Loffredo;Matthew L. Steinhauser;Steven M. Jay;Joseph Gannon.
Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
Heloisa Sawaya;Igal A. Sebag;Juan Carlos Plana;James L. Januzzi.
Circulation-cardiovascular Imaging (2012)
Early detection and prediction of cardiotoxicity in chemotherapy-treated patients.
Heloisa Sawaya;Igal A. Sebag;Juan Carlos Plana;James Louis Januzzi.
American Journal of Cardiology (2011)
Sildenafil Improves Exercise Capacity and Quality of Life in Patients with Systolic Heart Failure and Secondary Pulmonary Hypertension
Gregory D. Lewis;Ravi Shah;Khurram Shahzad;Janice M. Camuso.
Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.
Daniel Taliun;Daniel N. Harris;Michael D. Kessler;Jedidiah Carlson;Jedidiah Carlson.
Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans
Eugene P. Rhee;Susan Cheng;Susan Cheng;Martin G. Larson;Geoffrey A. Walford.
Journal of Clinical Investigation (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: